# Phase 3 Completion Report

_Audit follow-up date: 2026-07-22. Scope: Phase 3 reporting, automation, and integrations only. Phase 4+ work was not started._

## Executive summary

Phase 3 added repository-verifiable foundations for AI provenance reporting, billing/denial feedback ingestion, and EHR/FHIR-lite interoperability. These are deliberately pure helper and contract layers: they define safe shapes, validation rules, summary calculations, and import/export mappings without claiming live payer, EHR, or AI-governance production readiness.

## Features reviewed

- SmartNote, training, and AI-assisted workflows that need model/output provenance.
- ADR, documentation-impact, SmartNote denial guardrails, OASIS, and PDGM workflows that should consume payer denial feedback.
- Referral/patient workflows and help copy that imply EHR copy/export workflows.

## Features completed or improved

| Feature | Result |
|---|---|
| AI output provenance | Foundation added: normalize, validate, filter, and export provenance rows without raw prompt/response leakage. |
| Billing/denial feedback | Foundation added: normalize payer denial rows, classify denial categories, link affected workflow modules, and summarize counts/dollars. |
| FHIR-lite boundary | Foundation added: minimal Patient and referral ServiceRequest export mappings plus supported Patient import normalization and validation. |

## Defects or gaps corrected

- AI output evidence now has a shared registry/export shape that can support future dashboard work without copying raw prompt/response text into CSV-style reports.
- Denial feedback rows now have deterministic category/module mapping so payer feedback can be connected to documentation, OASIS, PDGM, referral, and ADR workflows.
- EHR interoperability now has a narrow, explicitly validated Patient + ServiceRequest boundary instead of vague copy-to-EHR assumptions.

## Backlog items completed, partially completed, or deferred

| ID | Status | Notes |
|---|---|---|
| P2-04 | Implemented repo-side | AI provenance normalization/filter/export helpers and tests added. Persisted dashboard, retention, and access-control policy remain future work. |
| P3-02 | Implemented repo-side | Denial feedback normalization/category/module linkage and summary helpers added. Live payer import and source-of-truth decisions remain external. |
| P3-03 | Implemented repo-side | FHIR-lite Patient and ServiceRequest import/export boundary helpers and tests added. Real EHR/FHIR endpoint integration remains external. |
| P3-01 | Not started | Patient portal is Phase 4 strategic scope. |
| P3-04 | Not started | SSO/enterprise audit export is Phase 5/enterprise scope. |
| P3-05 | Not started | Explainable risk/documentation-defense engine is Phase 4 strategic scope. |

## Database changes

No database or Base44 entity schema changes were made. Production AI provenance dashboards, payer denial stores, or EHR integration logs may require new persisted entities and indexes after product/security review.

## API changes

No API endpoints or hosted functions were added or changed. New modules define pure transformations and validation contracts for future endpoint work.

## Permission changes

No permissions were changed. Future endpoints must enforce server-side authorization because AI provenance, denial feedback, and EHR payloads can contain PHI and sensitive operational data.

## UI changes

No dashboard or integration UI was added in this slice. The new foundations are ready for later reviewable UI/API integration work.

## Tests added or updated

- `src/lib/aiProvenanceRegistry.test.js`.
- `src/components/billing/denialFeedback.test.js`.
- `src/lib/fhirLite.test.js`.
- `package.json` `test:utils` updated to include the new Phase 3 Node tests.

## Commands run and validation results

| Command | Result |
|---|---|
| `node --test src/lib/aiProvenanceRegistry.test.js src/components/billing/denialFeedback.test.js src/lib/fhirLite.test.js` | Passed; 9 focused Phase 3 tests passed. |
| `pnpm run test:utils` | Passed with Node 24.15.0 engine warning; 1,103 Node utility tests passed. |
| `pnpm run lint` | Passed with Node 24.15.0 engine warning after removing an unused import caught by lint. |
| `pnpm run typecheck` | Passed with Node 24.15.0 engine warning. |
| `pnpm run build` | Passed with Node 24.15.0 engine warning and expected local Base44 proxy notice because `VITE_BASE44_APP_BASE_URL` is unset. |
| `pnpm test` | Passed with Node 24.15.0 engine warning; included 1,103 Node utility tests, 14 contract tests, 48 security tests, 46 dedupe tests, and 418 Vitest tests. |

## Remaining limitations

- Live payer import validation requires payer sample files, business rules, and data-use approval.
- Real EHR/FHIR integration requires target EHR contracts, sandbox credentials, endpoint authentication, and security review.
- AI provenance persistence, retention, PHI redaction policy, and dashboard permissions require product/security approval.
- No authenticated E2E coverage was run because hosted Base44 credentials are unavailable.

## Manual verification required

1. Product/security approval of AI provenance retention fields, access roles, export policy, and PHI-minimization rules.
2. Payer sample-file validation for denial reason codes, claim IDs, amounts, reversals, and appeal outcomes.
3. EHR/FHIR sandbox testing for Patient and ServiceRequest export/import round trips.
4. Cross-role/cross-tenant tests for any future AI provenance, denial, or EHR integration endpoints.

## Recommended next scope

When explicitly authorized, Phase 4 should focus on strategic differentiators: patient portal and explainable risk/documentation-defense workflows. Do not begin Phase 4 until requested.
